Safety and efficacy of a combination of paromomycin and miltefosine for two vs. three courses in patients with post-kala-azar dermal leishmaniasis: an observational pilot study

Br J Dermatol. 2017 Aug;177(2):557-559. doi: 10.1111/bjd.15119. Epub 2017 Jul 2.
No abstract available

Publication types

  • Letter
  • Observational Study
  • Randomized Controlled Trial

MeSH terms

  • Administration, Oral
  • Adult
  • Antiprotozoal Agents / administration & dosage*
  • Antiprotozoal Agents / adverse effects
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Female
  • Humans
  • Injections, Intramuscular
  • Leishmaniasis, Cutaneous / drug therapy*
  • Leishmaniasis, Visceral / drug therapy
  • Male
  • Paromomycin / administration & dosage*
  • Paromomycin / adverse effects
  • Phosphorylcholine / administration & dosage
  • Phosphorylcholine / adverse effects
  • Phosphorylcholine / analogs & derivatives*
  • Pilot Projects
  • Treatment Outcome

Substances

  • Antiprotozoal Agents
  • Phosphorylcholine
  • miltefosine
  • Paromomycin